ALTIMMUNE CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of October 6th Deadline and Urges Investors to Contact the Firm - Altimmune ( NASDAQ:ALT )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Altimmune ( ALT ) To Contact Him Directly To Discuss Their Options
ALT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 6 Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ( NASDAQ:ALT ) between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Portnoy Law Firm Announces Class Action on Behalf of Altimmune, Inc. Investors - Altimmune ( NASDAQ:ALT )
LOS ANGELES, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Altimmune, Inc., ( "Altimmune" or the "Company" ) ( NASDAQ:ALT ) investors of a class action on behalf of investors that bought securities between August 10, 2023, and June 25, 2025, inclusive ( the "Class Period" ) .
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options
DEADLINE APPROACHING: Berger Montague Advises Altimmune, Inc. ( NASDAQ: ALT ) Investors to Inquire About a Securities Fraud Class Action by October 6, 2025 - Altimmune ( NASDAQ:ALT )
PHILADELPHIA, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Altimmune, Inc. ( NASDAQ:ALT ) ( "Altimmune" or the "Company" ) following the filing of a securities class action lawsuit filed on behalf of ...
ALTIMMUNE ( ALT ) DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors to Contact the Firm Before the October 6th Deadline in the Altimmune Class Action Lawsuit - Altimmune ( NASDAQ:ALT )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Altimmune ( ALT ) To Contact Him Directly To Discuss Their Options
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide - X4 Pharmaceuticals ( NASDAQ:XFOR ) , Altimmune ( NASDAQ:ALT )
Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH Dr. Arbet-Engels has led late-stage development, regulatory approvals and commercial launches for multiple successful franchises
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH ...
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ( NASDAQ: ALT ) of a class action securities lawsuit.
Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options
ALT DEADLINE: ROSEN, LEADING INVESTOR RIGHTS ATTORNEYS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Altimmune to Participate in Two Upcoming Investor Conferences - Altimmune ( NASDAQ:ALT )
GAITHERSBURG, Md., Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ALT, a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the Company's management team will participate and be ...
Altimmune to Participate in Two Upcoming Investor Conferences
GAITHERSBURG, Md., Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ( Nasdaq: ALT ) , a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the Company's management team will ...
Lost Money on Altimmune, Inc. ( ALT ) ? Urged to Join Class Action Before October 6, 2025 - Contact Levi & Korsinsky
Lost Money on Altimmune, Inc. (ALT)? Urged to Join Class Action Before October 6, 2025 - Contact Levi ...
ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
New York, New York-- ( Newsfile Corp. - September 20, 2025 ) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ( NASDAQ: ALT ) between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead ...
INVESTOR DEADLINE APPROACHING ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
INVESTOR DEADLINE APPROACHING ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 6, 2025 in Altimmune Lawsuit - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ALT of a class action securities lawsuit.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday - Altimmune ( NASDAQ:ALT ) , ASML Holding ( NASDAQ:ASML )
U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points on Thursday. Shares of Radian Group Inc. RDN rose sharply during Thursday's session after the company announced it entered into a definitive agreement to acquire Inigo for $1.7 billion.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options
Shareholders that lost money on Altimmune, Inc. ( ALT ) should contact Levi & Korsinsky about pending Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ALT of a class action securities lawsuit.
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Shareholders that lost money on Altimmune, Inc. ( ALT ) Urged to Join Class Action - Contact The Gross Law Firm to Learn More - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. ALT. Shareholders who purchased shares of ALT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer - Altimmune ( NASDAQ:ALT )
GAITHERSBURG, Md., Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ALT, a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced the appointment of Linda M.
Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer
GAITHERSBURG, Md., Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ( Nasdaq: ALT ) , a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced the appointment of Linda M.
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - Altimmune ( NASDAQ:ALT ) , SelectQuote ( NYSE:SLQT )
NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Altimmune, Inc. ALT and SelectQuote, Inc.
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 12, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Class Action Filed Against Altimmune, Inc. - Investors with Losses Encouraged to Contact Johnson Fistel - Altimmune ( NASDAQ:ALT )
SAN DIEGO, Sept. 12, 2025 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, PLLP, announces that a class action lawsuit has been filed on behalf of investors who purchased securities of Altimmune, Inc. ( "Altimmune" ) ALT between August 10, 2023 and June 25, 2025, inclusive ( the ...
Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options
Shareholders of Altimmune, Inc. Should Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ALT of a class action securities lawsuit.
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - Altimmune ( NASDAQ:ALT ) , SelectQuote ( NYSE:SLQT )
NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Altimmune, Inc. ALT, SelectQuote, Inc. SLQT and Spectrum Pharmaceuticals, Inc.
ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Important Notice to Long-Term Shareholders of Altimmune, Inc. ( NASDAQ: ALT ) ; Digimarc Corporation ( NASDAQ: DMRC ) ; Nutex Health Inc. ( NASDAQ: NUTX ) ; and Quantum Corporation ( NASDAQ: QMCO ) : Grabar Law Office is Investigating Claims on Your Behalf - Altimmune ( NASDAQ:ALT ) , Digimarc ( NASDAQ:DMRC )
PHILADELPHIA, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Altimmune, Inc. ALT. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options
Lost Money on Altimmune, Inc. ( ALT ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ALT of a class action securities lawsuit.
Altimmune, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 6, 2025 to Discuss Your Rights - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. ALT. Shareholders who purchased shares of ALT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options
Lost Money on Altimmune, Inc. ( ALT ) ? Join Class Action Before October 6, 2025 - Contact Levi & Korsinsky
Lost Money on Altimmune, Inc. (ALT)? Join Class Action Before October 6, 2025 - Contact Levi ...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - ( ALT )
NEW YORK, Aug. 30, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Altimmune ( NASDAQ:ALT )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options
October 6, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ALT of a class action securities lawsuit.
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Altimmune ( NASDAQ:ALT )
NEW YORK, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc. ( "Altimmune" or "the Company" ) ALT and certain of its officers.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Altimmune to Participate in Upcoming Investor Conferences
GAITHERSBURG, Md., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ( Nasdaq: ALT ) , a late clinical-stage biopharmaceutical company developing peptide-based therapeutics for liver and cardiometabolic diseases, today announced that management will participate and be available for one-on-one ...
Altimmune to Participate in Upcoming Investor Conferences - Altimmune ( NASDAQ:ALT )
GAITHERSBURG, Md., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ALT, a late clinical-stage biopharmaceutical company developing peptide-based therapeutics for liver and cardiometabolic diseases, today announced that management will participate and be available for one-on-one meetings at ...
ALT LAWSUIT ALERT: Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Altimmune ( NASDAQ:ALT )
NEW YORK, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ( "Altimmune" or the "Company" ) ALT of a class action securities lawsuit.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT - Altimmune ( NASDAQ:ALT )
NEW YORK, Aug. 24, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. ALT between August 10, 2023 and June 25, 2025 ( the "Class Period" ) , of the important October 6, 2025 lead plaintiff deadline.
Altimmune, Inc. ( ALT ) Securities Fraud: Contact Berger Montague To Discuss Your Rights
Altimmune, Inc. (ALT) Securities Fraud: Contact Berger Montague To Discuss Your Rights ...
